Polarean and Versarien
Episode 1481, Aug 06, 2019, 02:56 PM
Polarean discuss enrollment progress on their Phase iii trials and their planning in regards to submitting a new drug application to the FDA. Versarien talk about the LOI with a global apparel manufacturer and how their transport infrastructure technology preview event.
On the Vox Markets Podcast Today: 6th August 2019
Richard Hullihen, CEO of Polarean #POLX discusses enrollment progress on their Phase iii trials and their planning in regards to submitting a new drug application to the FDA.
Neill Ricketts, Chief Executive Officer of Versarien #VRS talks about the LOI with Global Apparel Manufacturer and how their transport infrastructure technology preview event.
(Interview starts at 16 minutes 3 seconds)
Plus the Top 5 Most Followed Companies & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours.
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast